80
Participants
Start Date
August 31, 2015
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2022
Platelet Rich Plasma
Patients will receive weekly PRP treatments with standard of care.
Standard of Care
Patients will receive weekly standard of care.
"TriHealth Hatton Research Institute , Bethesda North Hospital"
Lead Sponsor
ACR Biologics, LLC
INDUSTRY